2024年2月13日 · Hepatocellular carcinoma (HCC) is cancer in your liver. Although it can be life-threatening, catching it early can mean successful treatment with surgery or a liver transplant. Other treatments ease your symptoms and help you live longer.

2025年2月27日 · Surgical resection is a potentially curative therapy for patients without cirrhosis or for those patients with cirrhosis who lack portal hypertension, and liver transplantation is a potentially curative therapy for select patients who are not candidates for resection.

2023年4月28日 · Learn about innovative treatments for the most common type of liver cancer (hepatocellular carcinoma, or HCC), including liver transplant and ablation.

2024年10月14日 · Before instituting definitive therapy, it is best to treat the complications of cirrhosis, as follows: Surgical resection and liver transplantation provide the only chances of cure...

2025年3月26日 · Liver cancer includes two major types: hepatocellular carcinoma (HCC) and intrahepatic bile duct cancer. For information about bile duct cancer, see Bile Duct Cancer (Cholangiocarcinoma) Treatment. For more information about other, less common types of liver cancer, see the Cellular Classification of Primary Liver Cancer section.

2024年1月4日 · Tailoring treatment plans on the basis of individual patient factors, including liver function and disease stage, is crucial for optimizing the efficacy of hepatocellular carcinoma (HCC) interventions.

Primary prevention of HCC includes universal HBV vaccination and treatment of chronic HBV and HCV with antiviral therapies.

Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) represent the most prevalent primary liver cancers and pose significant challenges in oncology. While their etiology and incidence vary globally, the molecular landscape of these tumors is increasingly understood, offering new opportunities …

2025年3月3日 · Global incidence of hepatocellular carcinoma (HCC) is rising along with its mortality burden, and more than half of the patients require systemic therapy for advanced disease. ... With the approval of immune checkpoint inhibitors and tyrosine kinase inhibitors targeting tumor angiogenesis, the treatment landscape of advanced HCC has evolved ...

Dr He has been an investigator in numerous clinical trials focused on treatment strategies for advanced HCC, including CheckMate 040 (ClinicalTrials.gov identifier: NCT01658878) and CheckMate 9DW ...

AASLD develops evidence-based practice guidelines and practice guidances which are updated regularly by a multi-disciplinary panel of experts, including hepatologists, and include recommendations of preferred approaches to the diagnostic, therapeutic, and preventive aspects of …

Atezolizumab + bevacizumab (atezo + bev) or durvalumab + tremelimumab (durva + treme) may be offered first-line for patients with advanced HCC, Child-Pugh class A liver disease, and Eastern Cooperative Oncology Group performance status 0-1.

2025年3月8日 · Hepatocellular carcinoma (HCC) is a common malignant tumor of the digestive system and the third leading cause of cancer-related deaths worldwide [1, 2].With significant advances in surgical technique over the recent decade, hepatectomy is currently one of the most effective treatment options for HCC [].Unfortunately, the prognosis of surgical resection is still …

2023年4月14日 · Hepatocellular carcinoma, the most common type of liver cancer, has historically been difficult to treat since most people diagnosed with the disease have existing liver disease. But thanks to new research, there’s good news for hepatocellular carcinoma treatment, says Ahmed Kaseb, M.D.

2025年3月7日 · Hepatocellular carcinoma (HCC) is the second leading cause of global cancer-related death, and more than 80% of the global burden is borne by lower income countries.1 However, liver transplant (LT) and endovascular or percutaneous tumor destructive treatments provide cure rates approaching 90% at 5 years. Linkage to LT, rather than to chemotherapy, is …

This document presents official recommendations of the American Association for the Study of Liver Diseases (AASLD) on the surveillance, diagnosis, and treatment of hepatocellular carcinoma (HCC) occur-ring in the setting of adults with cirrhosis.

2020年6月2日 · There are quite a few methods of treating HCC. Surgical resection and liver transplant are associated with the best survival rates. As with most types of cancer, your treatment plan will...

2024年11月15日 · Understanding Durvalumab (Imfinzi) as a Treatment for Advanced Liver Cancer. Durvalumab, marketed as Imfinzi, represents a significant advancement in the treatment of advanced liver cancer, specifically hepatocellular carcinoma (HCC).Approved in the European Union as a first-line therapy, Imfinzi offers new hope for patients with advanced or …

2023年11月30日 · Generally, HCC treatment depends on factors such as the cancer stage, the tumor size, and how much function remains in the liver. In the advanced stage, the first-line treatment is immunotherapy...

2023年5月30日 · HCC is curable at an early stage. New locoregional treatments such as radioembolisation are showing impressive results. A combination of immunotherapy is the gold standard of first-line treatment for advanced hepatocellular cancer. There are more and more active systemic treatment options.